TILT Biotherapeutics Ltd is the leading company globally working in the area of enabling tumor.
Tilt Biotherapeutics has raised €61M across 4 funding rounds from 6 investors, most recently a Series B round in May 2025. Based in Helsinki, Finland; founded 2013; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-13 | Series B | €22M | European Innovation Council (EIC) Fund,Finnish Industry Investment (Tesi),Lifeline Ventures,Stephen Industries | View deal → |
| 2023-02-07 | Other | €22M | Lifeline Ventures | View deal → |
| 2022-06-14 | Other | €10M | Lifeline Ventures,Tesi | View deal → |
| 2020-06-16 | Early VC | €6.2M | Business Finland | View deal → |
